W27 - I don't understand your Abbott and Newman analogy.
I see Abbott and Newman competing with wannabes, also "making absurd promises they could not keep before an election."
Who would you suggest the board of IVX are competing with?
An alternate board for election?
Or do you think the board are playing mind games with the other biotechs involved in COPD and Lupus?
I think if a board keeps providing timelines and due dates and their only consistency is failure to meet those expectations then the conclusion is that they are out of their depth.
This has only provided "buying opportunity" for IVX.
I would like to see some selling opportunity - strength! and it won't be gained with aspirational timelines and goals.
IVX Price at posting:
4.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)